 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.11.1
- Non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a protein = ADP + a phosphoprotein
|
 |
 |
 |
 |
 |
ATP
|
+
|
protein
|
=
|
ADP
|
+
|
phosphoprotein
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
protein amino acid phosphorylation
|
1 term
|
 |
|
Biochemical function
|
protein kinase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Mol Cell
9:1227-1240
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation.
|
|
J.Yang,
P.Cron,
V.Thompson,
V.M.Good,
D.Hess,
B.A.Hemmings,
D.Barford.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Protein kinase B/Akt plays crucial roles in promoting cell survival and
mediating insulin responses. The enzyme is stimulated by phosphorylation at two
regulatory sites: Thr 309 of the activation segment and Ser 474 of the
hydrophobic motif, a conserved feature of many AGC kinases. Analysis of the
crystal structures of the unphosphorylated and Thr 309 phosphorylated states of
the PKB kinase domain provides a molecular explanation for regulation by Ser 474
phosphorylation. Activation by Ser 474 phosphorylation occurs via a disorder to
order transition of the alphaC helix with concomitant restructuring of the
activation segment and reconfiguration of the kinase bilobal structure. These
conformational changes are mediated by a phosphorylation-promoted interaction of
the hydrophobic motif with a channel on the N-terminal lobe induced by the
ordered alphaC helix and are mimicked by peptides corresponding to the
hydrophobic motif of PKB and potently by the hydrophobic motif of PRK2.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Role of αC Helix to Regulate Conformation of PKA
and PKB and Structure of Activation Segment and DFG Motif(A) αC
helix stabilizes an active state of PKA by interaction with pThr
197 of the activation segment via His 87, and Phe 185 of the DFG
motif via Ile 93 and Leu 94.(B) In PKB, disorder of the αC
helix prevents His 196 from interacting with pThr 309; Phe 294
of the DFG motif binds within the nucleotide binding site of ATP.
|
 |
Figure 7.
Figure 7. Conserved Residues of the Hydrophobic Motif, and
Residues of the N Lobe of PKB, Are Required for PIFtide and PKB
HM Peptide-Mediated Stimulation of PKB Kinase Activity(A)
Mutations of conserved hydrophobic motif residues of PIFtide and
PKB HM peptide reduce or eliminate their potential to activate
ΔPH-PKB-ΔC phosphorylated on Thr 309.(B) Mutations of
hydrophobic and electrostatic residues of the ΔPH-PKB-ΔC N
lobe hydrophobic groove reduces the stimulation of PKB activity
by 130 μM PIFtide. The positions of mutated residues on PKA and
PKB (R202D, V194A-V198A, and L225A) are shown colored pink in
Figures 2B and 2C and shown in Figure 5.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Mol Cell
(2002,
9,
1227-1240)
copyright 2002.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.L.Slomiany,
and
A.Slomiany
(2011).
Ghrelin suppression of Helicobacter pylori-induced S-nitrosylation-dependent Akt inactivation exerts modulatory influence on gastric mucin synthesis.
|
| |
Inflammopharmacology, 19,
89-97.
|
 |
|
|
|
|
 |
N.Jura,
X.Zhang,
N.F.Endres,
M.A.Seeliger,
T.Schindler,
and
J.Kuriyan
(2011).
Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms.
|
| |
Mol Cell, 42,
9.
|
 |
|
|
|
|
 |
S.S.Taylor,
and
A.P.Kornev
(2011).
Protein kinases: evolution of dynamic regulatory proteins.
|
| |
Trends Biochem Sci, 36,
65-77.
|
 |
|
|
|
|
 |
A.Najafov,
E.M.Sommer,
J.M.Axten,
M.P.Deyoung,
and
D.R.Alessi
(2010).
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
|
| |
Biochem J, 433,
357-369.
|
 |
|
|
|
|
 |
A.Vichalkovski,
E.Gresko,
D.Hess,
D.F.Restuccia,
and
B.A.Hemmings
(2010).
PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage.
|
| |
Oncogene, 29,
3554-3565.
|
 |
|
|
|
|
 |
C.A.Sparks,
and
D.A.Guertin
(2010).
Targeting mTOR: prospects for mTOR complex 2 inhibitors in cancer therapy.
|
| |
Oncogene, 29,
3733-3744.
|
 |
|
|
|
|
 |
C.C.Chen,
S.M.Jeon,
P.T.Bhaskar,
V.Nogueira,
D.Sundararajan,
I.Tonic,
Y.Park,
and
N.Hay
(2010).
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor.
|
| |
Dev Cell, 18,
592-604.
|
 |
|
|
|
|
 |
D.Finlay,
and
D.Cantrell
(2010).
Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration.
|
| |
Ann N Y Acad Sci, 1183,
149-157.
|
 |
|
|
|
|
 |
H.Carol,
C.L.Morton,
R.Gorlick,
E.A.Kolb,
S.T.Keir,
C.P.Reynolds,
M.H.Kang,
J.M.Maris,
C.Billups,
M.A.Smith,
P.J.Houghton,
and
R.B.Lock
(2010).
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing program.
|
| |
Pediatr Blood Cancer, 55,
1329-1337.
|
 |
|
|
|
|
 |
L.R.Pearce,
D.Komander,
and
D.R.Alessi
(2010).
The nuts and bolts of AGC protein kinases.
|
| |
Nat Rev Mol Cell Biol, 11,
9.
|
 |
|
|
|
|
 |
M.Pozuelo-Rubio,
N.R.Leslie,
J.Murphy,
and
C.Mackintosh
(2010).
Mechanism of activation of PKB/Akt by the protein phosphatase inhibitor Calyculin A.
|
| |
Cell Biochem Biophys, 58,
147-156.
|
 |
|
|
|
|
 |
S.Maerz,
and
S.Seiler
(2010).
Tales of RAM and MOR: NDR kinase signaling in fungal morphogenesis.
|
| |
Curr Opin Microbiol, 13,
663-671.
|
 |
|
|
|
|
 |
W.I.Wu,
W.C.Voegtli,
H.L.Sturgis,
F.P.Dizon,
G.P.Vigers,
and
B.J.Brandhuber
(2010).
Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition.
|
| |
PLoS One, 5,
e12913.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.J.Oh,
C.C.Wu,
S.J.Kim,
V.Facchinetti,
L.A.Julien,
M.Finlan,
P.P.Roux,
B.Su,
and
E.Jacinto
(2010).
mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide.
|
| |
EMBO J, 29,
3939-3951.
|
 |
|
|
|
|
 |
Y.Liao,
and
M.C.Hung
(2010).
Physiological regulation of Akt activity and stability.
|
| |
Am J Transl Res, 2,
19-42.
|
 |
|
|
|
|
 |
A.A.Santos,
C.M.Carvalho,
L.H.Florentino,
H.J.Ramos,
and
E.P.Fontes
(2009).
Conserved threonine residues within the A-loop of the receptor NIK differentially regulate the kinase function required for antiviral signaling.
|
| |
PLoS One, 4,
e5781.
|
 |
|
|
|
|
 |
B.X.Huang,
and
H.Y.Kim
(2009).
Probing Akt-inhibitor interaction by chemical cross-linking and mass spectrometry.
|
| |
J Am Soc Mass Spectrom, 20,
1504-1513.
|
 |
|
|
|
|
 |
C.C.Dibble,
J.M.Asara,
and
B.D.Manning
(2009).
Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1.
|
| |
Mol Cell Biol, 29,
5657-5670.
|
 |
|
|
|
|
 |
C.C.Huang,
K.Yoshino-Koh,
and
J.J.Tesmer
(2009).
A Surface of the Kinase Domain Critical for the Allosteric Activation of G Protein-coupled Receptor Kinases.
|
| |
J Biol Chem, 284,
17206-17215.
|
 |
|
|
|
|
 |
C.M.Gould,
N.Kannan,
S.S.Taylor,
and
A.C.Newton
(2009).
The Chaperones Hsp90 and Cdc37 Mediate the Maturation and Stabilization of Protein Kinase C through a Conserved PXXP Motif in the C-terminal Tail.
|
| |
J Biol Chem, 284,
4921-4935.
|
 |
|
|
|
|
 |
J.A.Soares,
F.G.Leite,
L.G.Andrade,
A.A.Torres,
L.P.De Sousa,
L.S.Barcelos,
M.M.Teixeira,
P.C.Ferreira,
E.G.Kroon,
T.Souto-Padrón,
and
C.A.Bonjardim
(2009).
Activation of the PI3K/Akt pathway early during vaccinia and cowpox virus infections is required for both host survival and viral replication.
|
| |
J Virol, 83,
6883-6899.
|
 |
|
|
|
|
 |
J.M.García-Martínez,
J.Moran,
R.G.Clarke,
A.Gray,
S.C.Cosulich,
C.M.Chresta,
and
D.R.Alessi
(2009).
Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR).
|
| |
Biochem J, 421,
29-42.
|
 |
|
|
|
|
 |
J.Park,
J.Feng,
Y.Li,
O.Hammarsten,
D.P.Brazil,
and
B.A.Hemmings
(2009).
DNA-dependent Protein Kinase-mediated Phosphorylation of Protein Kinase B Requires a Specific Recognition Sequence in the C-terminal Hydrophobic Motif.
|
| |
J Biol Chem, 284,
6169-6174.
|
 |
|
|
|
|
 |
K.Kaur,
and
T.T.Talele
(2009).
Structure-based CoMFA and CoMSIA study of indolinone inhibitors of PDK1.
|
| |
J Comput Aided Mol Des, 23,
25-36.
|
 |
|
|
|
|
 |
L.Du-Cuny,
Z.Song,
S.Moses,
G.Powis,
E.A.Mash,
E.J.Meuillet,
and
S.Zhang
(2009).
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
|
| |
Bioorg Med Chem, 17,
6983-6992.
|
 |
|
|
|
|
 |
L.Piao,
Y.Li,
K.J.Yang,
K.A.Park,
H.S.Byun,
M.Won,
J.Hong,
J.L.Kim,
G.R.Kweon,
G.M.Hur,
J.H.Seok,
J.Y.Cho,
T.Chun,
D.Hess,
R.Sack,
S.M.Maira,
D.P.Brazil,
B.A.Hemmings,
and
J.Park
(2009).
Heat shock protein 70-mediated sensitization of cells to apoptosis by Carboxyl-Terminal Modulator Protein.
|
| |
BMC Cell Biol, 10,
53.
|
 |
|
|
|
|
 |
L.R.Perumalsamy,
M.Nagala,
P.Banerjee,
and
A.Sarin
(2009).
A hierarchical cascade activated by non-canonical Notch signaling and the mTOR-Rictor complex regulates neglect-induced death in mammalian cells.
|
| |
Cell Death Differ, 16,
879-889.
|
 |
|
|
|
|
 |
M.Malakhova,
I.Kurinov,
K.Liu,
D.Zheng,
I.D'Angelo,
J.H.Shim,
V.Steinman,
A.M.Bode,
and
Z.Dong
(2009).
Structural diversity of the active N-terminal kinase domain of p90 ribosomal S6 kinase 2.
|
| |
PLoS One, 4,
e8044.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Muddassar,
F.A.Pasha,
M.M.Neaz,
Y.Saleem,
and
S.J.Cho
(2009).
Elucidation of binding mode and three dimensional quantitative structure-activity relationship studies of a novel series of protein kinase B/Akt inhibitors.
|
| |
J Mol Model, 15,
183-192.
|
 |
|
|
|
|
 |
R.Dettori,
S.Sonzogni,
L.Meyer,
L.A.Lopez-Garcia,
N.A.Morrice,
S.Zeuzem,
M.Engel,
A.Piiper,
S.Neimanis,
M.Frödin,
and
R.M.Biondi
(2009).
Regulation of the interaction between protein kinase C-related protein kinase 2 (PRK2) and its upstream kinase, 3-phosphoinositide-dependent protein kinase 1 (PDK1).
|
| |
J Biol Chem, 284,
30318-30327.
|
 |
|
|
|
|
 |
S.B.Widenmaier,
A.V.Sampaio,
T.M.Underhill,
and
C.H.McIntosh
(2009).
Noncanonical Activation of Akt/Protein Kinase B in {beta}-Cells by the Incretin Hormone Glucose-dependent Insulinotropic Polypeptide.
|
| |
J Biol Chem, 284,
10764-10773.
|
 |
|
|
|
|
 |
S.Xia,
Z.Chen,
L.W.Forman,
and
D.V.Faller
(2009).
PKCdelta survival signaling in cells containing an activated p21Ras protein requires PDK1.
|
| |
Cell Signal, 21,
502-508.
|
 |
|
|
|
|
 |
V.Calleja,
M.Laguerre,
and
B.Larijani
(2009).
3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase.
|
| |
J Chem Biol, 2,
11-25.
|
 |
|
|
|
|
 |
V.Calleja,
M.Laguerre,
P.J.Parker,
and
B.Larijani
(2009).
Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition.
|
| |
PLoS Biol, 7,
e17.
|
 |
|
|
|
|
 |
V.Hindie,
A.Stroba,
H.Zhang,
L.A.Lopez-Garcia,
L.Idrissova,
S.Zeuzem,
D.Hirschberg,
F.Schaeffer,
T.J.Jørgensen,
M.Engel,
P.M.Alzari,
and
R.M.Biondi
(2009).
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.
|
| |
Nat Chem Biol, 5,
758-764.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Garcia-Echeverria,
and
W.R.Sellers
(2008).
Drug discovery approaches targeting the PI3K/Akt pathway in cancer.
|
| |
Oncogene, 27,
5511-5526.
|
 |
|
|
|
|
 |
H.Schneider,
E.Valk,
R.Leung,
and
C.E.Rudd
(2008).
CTLA-4 activation of phosphatidylinositol 3-kinase (PI 3-K) and protein kinase B (PKB/AKT) sustains T-cell anergy without cell death.
|
| |
PLoS ONE, 3,
e3842.
|
 |
|
|
|
|
 |
K.J.Yang,
S.Shin,
L.Piao,
E.Shin,
Y.Li,
K.A.Park,
H.S.Byun,
M.Won,
J.Hong,
G.R.Kweon,
G.M.Hur,
J.H.Seok,
T.Chun,
D.P.Brazil,
B.A.Hemmings,
and
J.Park
(2008).
Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding.
|
| |
J Biol Chem, 283,
1480-1491.
|
 |
|
|
|
|
 |
L.Bozulic,
B.Surucu,
D.Hynx,
and
B.A.Hemmings
(2008).
PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival.
|
| |
Mol Cell, 30,
203-213.
|
 |
|
|
|
|
 |
N.Kannan,
A.F.Neuwald,
and
S.S.Taylor
(2008).
Analogous regulatory sites within the alphaC-beta4 loop regions of ZAP-70 tyrosine kinase and AGC kinases.
|
| |
Biochim Biophys Acta, 1784,
27-32.
|
 |
|
|
|
|
 |
S.F.Steinberg
(2008).
Structural basis of protein kinase C isoform function.
|
| |
Physiol Rev, 88,
1341-1378.
|
 |
|
|
|
|
 |
A.J.Caplan,
A.K.Mandal,
and
M.A.Theodoraki
(2007).
Molecular chaperones and protein kinase quality control.
|
| |
Trends Cell Biol, 17,
87-92.
|
 |
|
|
|
|
 |
A.Ruhland,
N.Leal,
and
P.E.Kima
(2007).
Leishmania promastigotes activate PI3K/Akt signalling to confer host cell resistance to apoptosis.
|
| |
Cell Microbiol, 9,
84-96.
|
 |
|
|
|
|
 |
C.Hauge,
T.L.Antal,
D.Hirschberg,
U.Doehn,
K.Thorup,
L.Idrissova,
K.Hansen,
O.N.Jensen,
T.J.Jørgensen,
R.M.Biondi,
and
M.Frödin
(2007).
Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation.
|
| |
EMBO J, 26,
2251-2261.
|
 |
|
|
|
|
 |
H.Al-Ali,
T.J.Ragan,
X.Gao,
and
T.K.Harris
(2007).
Reconstitution of modular PDK1 functions on trans-splicing of the regulatory PH and catalytic kinase domains.
|
| |
Bioconjug Chem, 18,
1294-1302.
|
 |
|
|
|
|
 |
J.Brognard,
E.Sierecki,
T.Gao,
and
A.C.Newton
(2007).
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
|
| |
Mol Cell, 25,
917-931.
|
 |
|
|
|
|
 |
L.M.Espinoza-Fonseca,
D.Kast,
and
D.D.Thomas
(2007).
Molecular dynamics simulations reveal a disorder-to-order transition on phosphorylation of smooth muscle myosin.
|
| |
Biophys J, 93,
2083-2090.
|
 |
|
|
|
|
 |
N.Kannan,
N.Haste,
S.S.Taylor,
and
A.F.Neuwald
(2007).
The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module.
|
| |
Proc Natl Acad Sci U S A, 104,
1272-1277.
|
 |
|
|
|
|
 |
O.Dormond,
J.C.Madsen,
and
D.M.Briscoe
(2007).
The effects of mTOR-Akt interactions on anti-apoptotic signaling in vascular endothelial cells.
|
| |
J Biol Chem, 282,
23679-23686.
|
 |
|
|
|
|
 |
S.Ranganathan,
Y.Wang,
F.G.Kern,
Z.Qu,
and
R.Li
(2007).
Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
|
| |
Proteins, 67,
709-719.
|
 |
|
|
|
|
 |
V.Calleja,
D.Alcor,
M.Laguerre,
J.Park,
B.Vojnovic,
B.A.Hemmings,
J.Downward,
P.J.Parker,
and
B.Larijani
(2007).
Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo.
|
| |
PLoS Biol, 5,
e95.
|
 |
|
|
|
|
 |
V.Kheifets,
and
D.Mochly-Rosen
(2007).
Insight into intra- and inter-molecular interactions of PKC: design of specific modulators of kinase function.
|
| |
Pharmacol Res, 55,
467-476.
|
 |
|
|
|
|
 |
A.Hergovich,
M.R.Stegert,
D.Schmitz,
and
B.A.Hemmings
(2006).
NDR kinases regulate essential cell processes from yeast to humans.
|
| |
Nat Rev Mol Cell Biol, 7,
253-264.
|
 |
|
|
|
|
 |
D.Benjamin,
M.Schmidlin,
L.Min,
B.Gross,
and
C.Moroni
(2006).
BRF1 protein turnover and mRNA decay activity are regulated by protein kinase B at the same phosphorylation sites.
|
| |
Mol Cell Biol, 26,
9497-9507.
|
 |
|
|
|
|
 |
J.M.Jansen,
M.F.Barry,
C.K.Yoo,
and
E.L.Weiss
(2006).
Phosphoregulation of Cbk1 is critical for RAM network control of transcription and morphogenesis.
|
| |
J Cell Biol, 175,
755-766.
|
 |
|
|
|
|
 |
L.Héron-Milhavet,
C.Franckhauser,
V.Rana,
C.Berthenet,
D.Fisher,
B.A.Hemmings,
A.Fernandez,
and
N.J.Lamb
(2006).
Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding.
|
| |
Mol Cell Biol, 26,
8267-8280.
|
 |
|
|
|
|
 |
L.Li,
K.Sampat,
N.Hu,
J.Zakari,
and
S.H.Yuspa
(2006).
Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes.
|
| |
J Biol Chem, 281,
3237-3243.
|
 |
|
|
|
|
 |
M.Engel,
V.Hindie,
L.A.Lopez-Garcia,
A.Stroba,
F.Schaeffer,
I.Adrian,
J.Imig,
L.Idrissova,
W.Nastainczyk,
S.Zeuzem,
P.M.Alzari,
R.W.Hartmann,
A.Piiper,
and
R.M.Biondi
(2006).
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.
|
| |
EMBO J, 25,
5469-5480.
|
 |
|
|
|
|
 |
M.G.Gold,
D.Barford,
and
D.Komander
(2006).
Lining the pockets of kinases and phosphatases.
|
| |
Curr Opin Struct Biol, 16,
693-701.
|
 |
|
|
|
|
 |
M.Tessier,
and
J.R.Woodgett
(2006).
Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3.
|
| |
J Biol Chem, 281,
23978-23989.
|
 |
|
|
|
|
 |
S.S.Yeong,
Y.Zhu,
D.Smith,
C.Verma,
W.G.Lim,
B.J.Tan,
Q.T.Li,
N.S.Cheung,
M.Cai,
Y.Z.Zhu,
S.F.Zhou,
S.L.Tan,
and
W.Duan
(2006).
The last 10 amino acid residues beyond the hydrophobic motif are critical for the catalytic competence and function of protein kinase Calpha.
|
| |
J Biol Chem, 281,
30768-30781.
|
 |
|
|
|
|
 |
T.Okada,
Y.Ishii,
K.Masujin,
A.Yasoshima,
J.Matsuda,
A.Ogura,
H.Nakayama,
T.Kunieda,
and
K.Doi
(2006).
The critical roles of serum/glucocorticoid-regulated kinase 3 (SGK3) in the hair follicle morphogenesis and homeostasis: the allelic difference provides novel insights into hair follicle biology.
|
| |
Am J Pathol, 168,
1119-1133.
|
 |
|
|
|
|
 |
X.Zhang,
S.Zhang,
H.Yamane,
R.Wahl,
A.Ali,
J.A.Lofgren,
and
R.L.Kendall
(2006).
Kinetic mechanism of AKT/PKB enzyme family.
|
| |
J Biol Chem, 281,
13949-13956.
|
 |
|
|
|
|
 |
Z.Shi,
K.A.Resing,
and
N.G.Ahn
(2006).
Networks for the allosteric control of protein kinases.
|
| |
Curr Opin Struct Biol, 16,
686-692.
|
 |
|
|
|
|
 |
C.C.Kumar,
and
V.Madison
(2005).
AKT crystal structure and AKT-specific inhibitors.
|
| |
Oncogene, 24,
7493-7501.
|
 |
|
|
|
|
 |
D.Chiu,
K.Ma,
A.Scott,
and
V.Duronio
(2005).
Acute activation of Erk1/Erk2 and protein kinase B/akt proceed by independent pathways in multiple cell types.
|
| |
FEBS J, 272,
4372-4384.
|
 |
|
|
|
|
 |
D.D.Sarbassov,
D.A.Guertin,
S.M.Ali,
and
D.M.Sabatini
(2005).
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.
|
| |
Science, 307,
1098-1101.
|
 |
|
|
|
|
 |
D.Komander,
G.Kular,
M.Deak,
D.R.Alessi,
and
D.M.van Aalten
(2005).
Role of T-loop phosphorylation in PDK1 activation, stability, and substrate binding.
|
| |
J Biol Chem, 280,
18797-18802.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.H.Kim,
J.H.Kim,
M.Ohba,
P.G.Suh,
and
S.H.Ryu
(2005).
Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.
|
| |
Mol Cell Biol, 25,
3194-3208.
|
 |
|
|
|
|
 |
J.Q.Cheng,
C.W.Lindsley,
G.Z.Cheng,
H.Yang,
and
S.V.Nicosia
(2005).
The Akt/PKB pathway: molecular target for cancer drug discovery.
|
| |
Oncogene, 24,
7482-7492.
|
 |
|
|
|
|
 |
J.R.Woodgett
(2005).
Recent advances in the protein kinase B signaling pathway.
|
| |
Curr Opin Cell Biol, 17,
150-157.
|
 |
|
|
|
|
 |
K.Du,
and
P.N.Tsichlis
(2005).
Regulation of the Akt kinase by interacting proteins.
|
| |
Oncogene, 24,
7401-7409.
|
 |
|
|
|
|
 |
M.P.Scheid,
M.Parsons,
and
J.R.Woodgett
(2005).
Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.
|
| |
Mol Cell Biol, 25,
2347-2363.
|
 |
|
|
|
|
 |
M.P.Wymann,
and
R.Marone
(2005).
Phosphoinositide 3-kinase in disease: timing, location, and scaffolding.
|
| |
Curr Opin Cell Biol, 17,
141-149.
|
 |
|
|
|
|
 |
S.Park,
D.Kim,
S.Kaneko,
K.M.Szewczyk,
S.V.Nicosia,
H.Yu,
R.Jove,
and
J.Q.Cheng
(2005).
Molecular cloning and characterization of the human AKT1 promoter uncovers its up-regulation by the Src/Stat3 pathway.
|
| |
J Biol Chem, 280,
38932-38941.
|
 |
|
|
|
|
 |
Y.Tominaga,
T.Tamgüney,
M.Kolesnichenko,
B.Bilanges,
and
D.Stokoe
(2005).
Translational deregulation in PDK-1-/- embryonic stem cells.
|
| |
Mol Cell Biol, 25,
8465-8475.
|
 |
|
|
|
|
 |
Z.Z.Chong,
F.Li,
and
K.Maiese
(2005).
Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease.
|
| |
Prog Neurobiol, 75,
207-246.
|
 |
|
|
|
|
 |
A.Kumar,
A.Vaid,
C.Syin,
and
P.Sharma
(2004).
PfPKB, a novel protein kinase B-like enzyme from Plasmodium falciparum: I. Identification, characterization, and possible role in parasite development.
|
| |
J Biol Chem, 279,
24255-24264.
|
 |
|
|
|
|
 |
A.Mora,
D.Komander,
D.M.van Aalten,
and
D.R.Alessi
(2004).
PDK1, the master regulator of AGC kinase signal transduction.
|
| |
Semin Cell Dev Biol, 15,
161-170.
|
 |
|
|
|
|
 |
C.Rüegg,
O.Dormond,
and
A.Mariotti
(2004).
Endothelial cell integrins and COX-2: mediators and therapeutic targets of tumor angiogenesis.
|
| |
Biochim Biophys Acta, 1654,
51-67.
|
 |
|
|
|
|
 |
D.Auguin,
P.Barthe,
C.Royer,
M.H.Stern,
M.Noguchi,
S.T.Arold,
and
C.Roumestand
(2004).
Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins.
|
| |
J Biol Chem, 279,
35890-35902.
|
 |
|
|
|
|
 |
I.Remy,
and
S.W.Michnick
(2004).
Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B/Akt.
|
| |
Mol Cell Biol, 24,
1493-1504.
|
 |
|
|
|
|
 |
J.Feng,
J.Park,
P.Cron,
D.Hess,
and
B.A.Hemmings
(2004).
Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase.
|
| |
J Biol Chem, 279,
41189-41196.
|
 |
|
|
|
|
 |
K.J.Smith,
P.S.Carter,
A.Bridges,
P.Horrocks,
C.Lewis,
G.Pettman,
A.Clarke,
M.Brown,
J.Hughes,
M.Wilkinson,
B.Bax,
and
A.Reith
(2004).
The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein.
|
| |
Structure, 12,
1067-1077.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Hiromura,
F.Okada,
T.Obata,
D.Auguin,
T.Shibata,
C.Roumestand,
and
M.Noguchi
(2004).
Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the proto-oncogene TCL1.
|
| |
J Biol Chem, 279,
53407-53418.
|
 |
|
|
|
|
 |
M.R.Stegert,
R.Tamaskovic,
S.J.Bichsel,
A.Hergovich,
and
B.A.Hemmings
(2004).
Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein.
|
| |
J Biol Chem, 279,
23806-23812.
|
 |
|
|
|
|
 |
M.Schmidlin,
M.Lu,
S.A.Leuenberger,
G.Stoecklin,
M.Mallaun,
B.Gross,
R.Gherzi,
D.Hess,
B.A.Hemmings,
and
C.Moroni
(2004).
The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B.
|
| |
EMBO J, 23,
4760-4769.
|
 |
|
|
|
|
 |
N.J.Dibb,
S.M.Dilworth,
and
C.D.Mol
(2004).
Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
|
| |
Nat Rev Cancer, 4,
718-727.
|
 |
|
|
|
|
 |
O.J.Shah,
and
T.Hunter
(2004).
Critical role of T-loop and H-motif phosphorylation in the regulation of S6 kinase 1 by the tuberous sclerosis complex.
|
| |
J Biol Chem, 279,
20816-20823.
|
 |
|
|
|
|
 |
S.J.Bichsel,
R.Tamaskovic,
M.R.Stegert,
and
B.A.Hemmings
(2004).
Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein.
|
| |
J Biol Chem, 279,
35228-35235.
|
 |
|
|
|
|
 |
Z.B.Xu,
D.Chaudhary,
S.Olland,
S.Wolfrom,
R.Czerwinski,
K.Malakian,
L.Lin,
M.L.Stahl,
D.Joseph-McCarthy,
C.Benander,
L.Fitz,
R.Greco,
W.S.Somers,
and
L.Mosyak
(2004).
Catalytic domain crystal structure of protein kinase C-theta (PKCtheta).
|
| |
J Biol Chem, 279,
50401-50409.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.J.Collins,
M.Deak,
J.S.Arthur,
L.J.Armit,
and
D.R.Alessi
(2003).
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.
|
| |
EMBO J, 22,
4202-4211.
|
 |
|
|
|
|
 |
D.G.Wansink,
R.E.van Herpen,
M.M.Coerwinkel-Driessen,
P.J.Groenen,
B.A.Hemmings,
and
B.Wieringa
(2003).
Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization.
|
| |
Mol Cell Biol, 23,
5489-5501.
|
 |
|
|
|
|
 |
D.T.Lodowski,
J.A.Pitcher,
W.D.Capel,
R.J.Lefkowitz,
and
J.J.Tesmer
(2003).
Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma.
|
| |
Science, 300,
1256-1262.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.R.Gold
(2003).
Akt is TCL-ish: implications for B-cell lymphoma.
|
| |
Trends Immunol, 24,
104-108.
|
 |
|
|
|
|
 |
R.Tamaskovic,
S.J.Bichsel,
H.Rogniaux,
M.R.Stegert,
and
B.A.Hemmings
(2003).
Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase.
|
| |
J Biol Chem, 278,
6710-6718.
|
 |
|
|
|
|
 |
X.Huang,
M.Begley,
K.A.Morgenstern,
Y.Gu,
P.Rose,
H.Zhao,
and
X.Zhu
(2003).
Crystal structure of an inactive Akt2 kinase domain.
|
| |
Structure, 11,
21-30.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.P.Brazil,
J.Park,
and
B.A.Hemmings
(2002).
PKB binding proteins. Getting in on the Akt.
|
| |
Cell, 111,
293-303.
|
 |
|
|
|
|
 |
E.J.Goldsmith,
and
C.I.Chang
(2002).
Another twist in helix C and a missing pocket.
|
| |
Structure, 10,
888-889.
|
 |
|
|
|
|
 |
J.Xu,
D.Liu,
and
Z.Songyang
(2002).
The role of Asp-462 in regulating Akt activity.
|
| |
J Biol Chem, 277,
35561-35566.
|
 |
|
|
|
|
 |
J.Yang,
P.Cron,
V.M.Good,
V.Thompson,
B.A.Hemmings,
and
D.Barford
(2002).
Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.
|
| |
Nat Struct Biol, 9,
940-944.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.C.Foukas,
N.Daniele,
C.Ktori,
K.E.Anderson,
J.Jensen,
and
P.R.Shepherd
(2002).
Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities.
|
| |
J Biol Chem, 277,
37124-37130.
|
 |
|
|
|
|
 |
M.Frödin,
T.L.Antal,
B.A.Dümmler,
C.J.Jensen,
M.Deak,
S.Gammeltoft,
and
R.M.Biondi
(2002).
A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation.
|
| |
EMBO J, 21,
5396-5407.
|
 |
|
|
|
|
 |
M.M.Hill,
J.Feng,
and
B.A.Hemmings
(2002).
Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1.
|
| |
Curr Biol, 12,
1251-1255.
|
 |
|
|
|
|
 |
N.M.Conus,
K.M.Hannan,
B.E.Cristiano,
B.A.Hemmings,
and
R.B.Pearson
(2002).
Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase.
|
| |
J Biol Chem, 277,
38021-38028.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|